With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeted Degradation of Proliferative Transcription Factors in Pediatric Cancers||University of California at Santa Cruz / Seth Rubin, PhD||Innovation Grants||2017||California|
|Targeting Childhood Brain Cancer in a Dish to Catalyze New Therapies||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2017||California|
|Role of Protocadherin-9 in Enabling Leukemia Cell Colonization of the CNS||National Jewish Health / Jordan Jacobelli, PhD||Innovation Grants||2017||Colorado|
|Development of Nanoparticle-Encapsulated Chemo/Radio-Sensitizers for Intrathecal Delivery||Yale School of Medicine / Ranjit S. Bindra, MD/PhD & Mark Saltzman, PhD||Innovation Grants||2017||Connecticut|
|Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-Free DNA||University of Chicago / Susan Cohn, MD & Chuan He PhD||Innovation Grants||2017||Illinois|
|3-D Printed Self-fitting Shape Memory Bone Grafts for Smart Pediatric Skeletal Reconstruction||University of Massachusetts Medical School / Jie Song, PhD||Innovation Grants||2017||Massachusetts|
|Mechanisms of OTX2 Mediated Chromatin Regulation in Medulloblastoma||Massachusetts General Hospital / Miguel Rivera, MD||Innovation Grants||2017||Massachusetts|
|Targeting BRD9 in Sarcoma||Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD||Innovation Grants||2017||Massachusetts|
|Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas||University of Manitoba / Tamra Werbowetski-Ogilvie, PhD||Innovation Grants||2017||Manitoba|
|Novel Approaches for Epigenetic Therapy for Relapsed Acute Lymphoblastic Leukemia||The Johns Hopkins University School of Medicine / Linda Resar, MD & Andrei Thomas-Tikhonenko, PhD||Innovation Grants||2017||Maryland|